NEW THERAPEUTIC AGENTS
A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53....
Saved in:
| Main Authors | , , , , , , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
30.12.2009
|
| Online Access | Get full text |
Cover
Loading…
| Abstract | A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53.
L'invention concerne des composés représentés par la formule (I): ou des composés représentés par la formule (II) ou bien des sels de qualité pharmaceutique de ces composés, ainsi que leur utilisation thérapeutique, en particulier pour le traitement du cancer ou comme inhibiteur de l'interaction entre la protéine et MDM2 et p53. |
|---|---|
| AbstractList | A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53.
L'invention concerne des composés représentés par la formule (I): ou des composés représentés par la formule (II) ou bien des sels de qualité pharmaceutique de ces composés, ainsi que leur utilisation thérapeutique, en particulier pour le traitement du cancer ou comme inhibiteur de l'interaction entre la protéine et MDM2 et p53. |
| Author | GRIFFIN ROGER JOHN HARDCASTLE IAN, ROBERT RIEDINGER CHRISTIANE VALEUR ERIC WATSON ANNA, FRANCES NOBLE MARTIN GOLDING BERNARD, THOMAS |
| Author_xml | – fullname: HARDCASTLE IAN, ROBERT – fullname: GRIFFIN ROGER JOHN – fullname: GOLDING BERNARD, THOMAS – fullname: RIEDINGER CHRISTIANE – fullname: VALEUR ERIC – fullname: WATSON ANNA, FRANCES – fullname: NOBLE MARTIN |
| BookMark | eNrjYmDJy89L5WQQ83MNVwjxcA1yDHANDfF0VnB0d_ULCeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGBpaGpmbmxqaORsbEqQIABaIh4w |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | NOUVEAUX AGENTS THÉRAPEUTIQUES |
| ExternalDocumentID | WO2009156735A2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_WO2009156735A23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 16:00:59 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_WO2009156735A23 |
| Notes | Application Number: WO2009GB01599 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091230&DB=EPODOC&CC=WO&NR=2009156735A2 |
| ParticipantIDs | epo_espacenet_WO2009156735A2 |
| PublicationCentury | 2000 |
| PublicationDate | 20091230 |
| PublicationDateYYYYMMDD | 2009-12-30 |
| PublicationDate_xml | – month: 12 year: 2009 text: 20091230 day: 30 |
| PublicationDecade | 2000 |
| PublicationYear | 2009 |
| RelatedCompanies | GRIFFIN ROGER JOHN HARDCASTLE IAN, ROBERT RIEDINGER CHRISTIANE VALEUR ERIC WATSON ANNA, FRANCES NOBLE MARTIN CANCER RESEARCH TECHNOLOGY LIMITED GOLDING BERNARD, THOMAS |
| RelatedCompanies_xml | – name: WATSON ANNA, FRANCES – name: NOBLE MARTIN – name: GRIFFIN ROGER JOHN – name: RIEDINGER CHRISTIANE – name: HARDCASTLE IAN, ROBERT – name: CANCER RESEARCH TECHNOLOGY LIMITED – name: GOLDING BERNARD, THOMAS – name: VALEUR ERIC |
| Score | 2.7629375 |
| Snippet | A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description,... |
| SourceID | epo |
| SourceType | Open Access Repository |
| Title | NEW THERAPEUTIC AGENTS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091230&DB=EPODOC&locale=&CC=WO&NR=2009156735A2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp8OPKQWlb8XaNF36MKRLU6uwtszO7W0sNQVB5nAV_32vtdU97S3k4JIc_O4jyd0B3Ci3vyCSECNjVBm2s5CGZNQ0SldaKpmjVSrznUeRE07spxmdteC9yYWp6oR-V8UREVEZ4r2o9PXq_xLLr_5Wrm_lG0593AfpwNeb6NhFRWzq_nAgktiPuc45xm16NP6lUadPqIcKe6d0pMtK--JlWOalrDaNSnAIuwnyWxZH0FLLDuzzpvdaB_ZG9ZM3Dmv0rY-hG4mploZi7CVikj5yzXsQUfp8AteBSHlo4ALzv_PMp_HmbkgX2hjpq1PQFkze5RRdBEsS28oZe1WKWRKF7CqZueoMets4nW8nX8CBVTc_IGYP2sXnl7pEi1rIq0oQP6qpdto |
| link.rule.ids | 230,309,786,891,25594,76904 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq8VH1YCSWzBm8zwUSZONqTYPamp7C9m4AUFqsRH_vpPYaE-9LTswuzswj293ZwbghltGRhghUm5qXFL1jEnM1GSpCqUZZwV6pSrfOQh1f6o-zrV5C96bXJi6Tuh3XRwRNSpHfS9re738v8Ry67-Vq1v2hlMf914ycMUGHVtoiGXRHQ5oHLmRIzoO4jYxnPzSNN0gmo0Ge8dAUFhV2qcvwyovZbnpVLwD2I2R36I8hBZfdKHjNL3XurAXrJ-8cbjWvtUR9EI6ExKfTuyYTpORI9gPNEyej-Hao4njS7hA-needBZt7ob0oI1In5-AkJnsrtAwRFAYUZXCNF85NxWGQrY4yy1-Cv1tnM62k6-g4yfBOB2Pwqdz2FfWjRCI3Id2-fnFL9C7luyyFsoPXyd5xQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NEW+THERAPEUTIC+AGENTS&rft.inventor=HARDCASTLE+IAN%2C+ROBERT&rft.inventor=GRIFFIN+ROGER+JOHN&rft.inventor=GOLDING+BERNARD%2C+THOMAS&rft.inventor=RIEDINGER+CHRISTIANE&rft.inventor=VALEUR+ERIC&rft.inventor=WATSON+ANNA%2C+FRANCES&rft.inventor=NOBLE+MARTIN&rft.date=2009-12-30&rft.externalDBID=A2&rft.externalDocID=WO2009156735A2 |